We are live on ! Find out more
CIP

Chartwell Investment Partners Portfolio holdings

AUM $2.91B
1-Year Est. Return 40.48%
This Fund
S&P 500
This Quarter Est. Return
+10.24%
1 Year Est. Return
+40.48%
3 Year Est. Return
+57.16%
5 Year Est. Return
+148.97%
10 Year Est. Return
+397.87%
AUM
$5.61B
AUM Growth
+$1.61M
Cap. Flow
-$357M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.1%
Holding
464
New
65
Increased
116
Reduced
184
Closed
45

Top Buys

Rank Stock Value
1
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$58.3M
2
RDN icon
Radian Group
RDN
+$50.8M
3
PHM icon
Pultegroup
PHM
+$42M
4
CAVM
Cavium, Inc.
CAVM
+$39.7M
5
ADBE icon
Adobe
ADBE
+$34M

Top Sells

Rank Stock Value
1
MAN icon
ManpowerGroup
MAN
+$76.7M
2
SSNC icon
SS&C Technologies
SSNC
+$71.2M
3
NXPI icon
NXP Semiconductors
NXPI
+$57.6M
4
JCP
J.C. Penney Company, Inc.
JCP
+$56.8M
5
CRM icon
Salesforce
CRM
+$53.2M

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Financials 17.22%
3 Consumer Discretionary 15.09%
4 Healthcare 11.48%
5 Industrials 11.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EW icon
201
Edwards Lifesciences
EW
$51.5B
$8.21M 0.15%
+204,195
New +$7.69M
RIO icon
202
Rio Tinto
RIO
$162B
$8.14M 0.15%
243,870
+139,200
+133% +$4.44M
NX icon
203
Quanex
NX
$959M
$7.68M 0.14%
445,210
+196,280
+79% +$3.79M
MAT icon
204
Mattel
MAT
$4.21B
$7.63M 0.14%
251,915
-62,795
-20% -$2.05M
DGX icon
205
Quest Diagnostics
DGX
$26.3B
$7.43M 0.13%
87,814
-58,910
-40% -$4.95M
FTNT icon
206
Fortinet
FTNT
$117B
$7.33M 0.13%
+992,225
New +$6.93M
ARCC icon
207
Ares Capital
ARCC
$14.1B
$7.31M 0.13%
471,526
+27,424
+6% +$421K
LOPE icon
208
Grand Canyon Education
LOPE
$3.88B
$7.28M 0.13%
180,250
-534,018
-75% -$22.2M
EXC icon
209
Exelon
EXC
$46.7B
$7.25M 0.13%
305,117
+47,516
+18% +$1.19M
HAPN
210
Happen Inc
HAPN
$2.27B
$7.01M 0.13%
+226,888
New +$5.89M
CCI icon
211
Crown Castle
CCI
$31.9B
$6.86M 0.12%
72,767
+6,631
+10% +$638K
QRVO icon
212
Qorvo
QRVO
$8.41B
$6.8M 0.12%
+121,980
New +$6.92M
FORM icon
213
FormFactor
FORM
$9B
$6.75M 0.12%
+621,854
New +$6.26M
DHR icon
214
Danaher
DHR
$141B
$6.72M 0.12%
+96,698
New +$6.85M
CVS icon
215
CVS Health
CVS
$123B
$6.72M 0.12%
75,500
+6,500
+9% +$614K
FRC
216
DELISTED
First Republic Bank
FRC
$6.64M 0.12%
86,150
+9,200
+12% +$677K
NICE icon
217
Nice
NICE
$5.69B
$6.64M 0.12%
+99,158
New +$6.6M
PCTI
218
DELISTED
PCTEL, Inc. Common Stock
PCTI
$6.58M 0.12%
1,244,656
-394,001
-24% -$2M
BLK icon
219
Blackrock
BLK
$175B
$6.48M 0.12%
17,874
-4,769
-21% -$1.74M
NWL icon
220
Newell Brands
NWL
$2.56B
$6.43M 0.11%
122,142
– –
PAYC icon
221
Paycom
PAYC
$10.1B
$6.41M 0.11%
+127,940
New +$6.25M
TMO icon
222
Thermo Fisher Scientific
TMO
$214B
$6.36M 0.11%
40,000
– –
NBIX icon
223
Neurocrine Biosciences
NBIX
$16.2B
$6.18M 0.11%
+121,955
New +$6.07M
AA icon
224
Alcoa
AA
$12.5B
$6.12M 0.11%
251,196
+44,057
+21% +$1.07M
VRTX icon
225
Vertex Pharmaceuticals
VRTX
$123B
$6.08M 0.11%
+69,715
New +$6.59M
7 8
9
10 11

Similar funds

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Chartwell Investment Partners's Q3 2016 Portfolio in Review

As of Q3 2016, Chartwell Investment Partners held 464 positions worth $5.61B, up 0.03% from $5.61B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Chartwell Investment Partners withdrew a net $357M in Q3 2016, closing 45 positions and reducing 184 holdings. Its most notable exit was ManpowerGroup, an estimated $76.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Chartwell Investment Partners opened a new position in BioMarin Pharmaceuticals worth $57.3M.

  • Chartwell Investment Partners's largest Q3 2016 buy was BioMarin Pharmaceuticals: 619,625 shares worth $57.3M.
  • Chartwell Investment Partners added most to Pultegroup in Q3 2016, an estimated $42M increase.
  • Chartwell Investment Partners's biggest Q3 2016 reduction was SS&C Technologies, cutting an estimated $71.2M.
  • Chartwell Investment Partners fully exited ManpowerGroup in Q3 2016, selling an estimated $76.7M.
  • Chartwell Investment Partners's ten largest holdings make up 16% of its $5.61B portfolio in Q3 2016.
  • Chartwell Investment Partners opened 65 new positions and closed 45 in Q3 2016.
  • Chartwell Investment Partners's portfolio value rose 0.03% quarter-over-quarter to $5.61B.

Based on Chartwell Investment Partners's 13F filing for Q3 2016, filed 15 Nov 2016.